Table 1. Expression of PRLR in normal and cancerous ovarian and endometrial tissue.
| OVARIAN | Total N | Positive N | % Positive |
|---|---|---|---|
| Tumor | |||
| Total | 69 | 56 | 80% |
| CCC | 3 | 1 | 33% |
| Endo | 3 | 2 | 67% |
| M | 8 | 8 | 100% |
| S | 53 | 42 | 79% |
| Grade | |||
| 1 | 12 | 12 | 100% |
| 2 | 29 | 21 | 72% |
| 3 | 24 | 20 | 83% |
| Stage | |||
| 1 | 13 | 3 | 77% |
| 2 | 27 | 22 | 82% |
| 3-4 | 30 | 24 | 80% |
| Healthy | 10 | 0 | 0% |
| ENDOMETRIAL | |||
| Tumor | |||
| Total | 57 | 44 | 77% |
| Grade | |||
| 1 | 32 | 29 | 90.1% |
| 2 | 32 | 24 | 75% |
| 3 | 23 | 15 | 65% |
| Stage | |||
| 1 | 52 | 45 | 81% |
| 2-3 | 8 | 6 | 75% |
| Healthy | 15 | 2 | 13% |
|
Tumor-Adjacent Non-cancerous |
11 | 3 | 27% |
| Hyperplasia | 20 | 15 | 75% |
| Endometritis | 5 | 3 | 75% |